Abbott India up 19% as parent firm gets US FDA nod for rapid COVID-19 test

Shares of Abbott India surged 19 per cent to hit a new high of Rs 16,869 on the BSE on Monday in an otherwise weak market on report that Abbott Laboratories, USA,  the ulitmate holding company, has received the approval to launch 5-minute coronavirus (COVID-19) test for use almost anywhere. Abbott India is a subsidiary of Abbott Laboratories of USA.

According to a Bloomberg report, Abbott Laboratories is unveiling a COVID-19 test that can tell if someone is infected in as little as five minutes, and is so small and portable it can be used in almost any health-care